← Leaderboards
Lara Ruth Dugas
Loyola University Chicago
$4,800,525
Attributed
$6,571,347
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2017–23$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,571,347 · 2
By mechanism
R01$6,571,347 · 2
Top collaborators
- Brian Thomas Layden5 shared
Most similar at Loyola University Chicago
Same institution · by research overlap
- Richard Stanley Cooper$14,960,406
- Basmattee Boodram$4,816,495
- Ramon Angel Durazo-Arvizu$3,032,490
- Jonathan Ozik$2,212,458
- Harel Dahari$6,227,500
Others in their field
Other Emerging Leaders on “Mediation”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- James Dale Berry · Brigham And Women'S Hospital$25,538,716
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
- Gary Fanger · Rise Therapeutics, Llc$17,847,765
Research focus
MediationPhysical ActivityEpidemiologyMeasurementPathway InteractionsParticipantEconomic DevelopmentEpidemiological ModelGhanaLongitudinal DesignObesity RiskObesityAfricanDietAdultCohortEnvironmentEnvironmental ExposureFecesGeographyGut MicrobiotaJamaicaMicrobiotaPopulations At Risk
Grant awards (10)
METS-Sleep: Sleep timing, gut microbiota and cardiometabolic risk across the Epidemiologic Transition$608,523
R01 · FY2023 · HL · contact PI
METS-Sleep: Sleep timing, gut microbiota and cardiometabolic risk across the Epidemiologic Transition$714,359
R01 · FY2022 · HL · contact PI
METS-Sleep: Sleep timing, gut microbiota and cardiometabolic risk across the Epidemiologic Transition$697,543
R01 · FY2021 · HL · contact PI
Gut microbiota, short chain fatty acids, and adiposity across the epidemiologic transition$565,040
R01 · FY2021 · DK · contact PI
METS-Sleep: Sleep timing, gut microbiota and cardiometabolic risk across the Epidemiologic Transition$722,832
R01 · FY2020 · HL · contact PI
Gut microbiota, short chain fatty acids, and adiposity across the epidemiologic transition$580,402
R01 · FY2020 · DK · contact PI
METS-Sleep: Sleep timing, gut microbiota and cardiometabolic risk across the Epidemiologic Transition$798,387
R01 · FY2019 · HL · contact PI
Gut microbiota, short chain fatty acids, and adiposity across the epidemiologic transition$600,631
R01 · FY2019 · DK · contact PI
Gut microbiota, short chain fatty acids, and adiposity across the epidemiologic transition$604,299
R01 · FY2018 · DK · contact PI
Gut microbiota, short chain fatty acids, and adiposity across the epidemiologic transition$679,331
R01 · FY2017 · DK · contact PI